On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Dartmouth Institute for Health Policy and Clinical Practice

InstitutionResearch output, impact & collaborations

Dartmouth Institute for Health Policy and Clinical Practice is a institution indexed in ScholarIQ from OpenAlex.

What is known about Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQrecord summary

Dartmouth Institute for Health Policy and Clinical Practice is a research organisation in Lebanon, US. OpenAlex records 5,400 works and 453,241 citations for it. 799 researchers list it as their most recent affiliation.

How many works does Dartmouth Institute for Health Policy and Clinical Practice have?

ScholarIQindexed works

Dartmouth Institute for Health Policy and Clinical Practice has 5,400 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Dartmouth Institute for Health Policy and Clinical Practice have?

ScholarIQcitation count

Dartmouth Institute for Health Policy and Clinical Practice has 453,241 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQresearcher count

Dartmouth Institute for Health Policy and Clinical Practice has 799 researchers in the ScholarIQ index.

What is the average h-index at Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQavg h-index

Dartmouth Institute for Health Policy and Clinical Practice has an average h-index of 105 in OpenAlex.

What is the ROR of Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQror

The ROR for Dartmouth Institute for Health Policy and Clinical Practice is on the source record.

What is the OpenAlex record for Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQopenalex

The OpenAlex for Dartmouth Institute for Health Policy and Clinical Practice is on the source record.

What is the Wikidata of Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQwikidata

The Wikidata for Dartmouth Institute for Health Policy and Clinical Practice is on the source record.

Who are the most-cited researchers behind Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQtop researchers by citations
1
William A. Catterall · Ion channel regulation and function
655 works92,660 citations
2
John D. Birkmeyer · Cardiac, Anesthesia and Surgical Outcomes
341 works43,165 citations
3
Marc S. Ernstoff · Cancer Immunotherapy and Biomarkers
568 works37,583 citations
4
Gregory J. McHugo · Schizophrenia research and treatment
192 works17,676 citations

What are the most-cited papers on Dartmouth Institute for Health Policy and Clinical Practice?

ScholarIQmost cited works
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson
Journal of Clinical Oncology. 20183,734 CitationsOPEN ACCESS
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
J M Kirkwood, M H Strawderman, Marc S. Ernstoff, Thomas J. Smith, E C Borden, Ronald H. Blum
Journal of Clinical Oncology. 19962,106 Citations
High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
John M. Kirkwood, Joseph G. Ibrahim, Vernon K. Sondak, Jon Richards, Lawrence E. Flaherty, Marc S. Ernstoff, Thomas J. Smith, Uma Rao, Mary Steele, Ronald H. Blum
Journal of Clinical Oncology. 2000923 Citations
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R. Brahmer, Hamzah Abu‐Sbeih, Paolo A. Ascierto, Jill Brufsky, Laura C. Cappelli, Frank B. Cortazar, David E. Gerber, Lamya Hamad, Eric Hansen, Douglas B. Johnson, Mario E. Lacouture, Gregory A. Masters, Jarushka Naidoo, Michele Nanni, Miguel‐Angel Perales, Igor Puzanov, Bianca Santomasso, Satish Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A. Sosman, Michelle Turner, Marc S. Ernstoff
Journal for ImmunoTherapy of Cancer. 2021854 CitationsOPEN ACCESS
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone
Journal of the National Comprehensive Cancer Network. 2019562 CitationsOPEN ACCESS

How much of the research on Dartmouth Institute for Health Policy and Clinical Practice is open access?

ScholarIQopen access share
63%OPEN ACCESS
Gold
13%
Green
25%
Hybrid
0%
Bronze
25%
Closed
38%

Related on ScholarIQ

470M+ articles · 14-day free trial